There were differences in age, HER2 status, ER, and PR status between male and female breast cancers (P < 0.05), with male breast cancers occurring more commonly above 60 years of age, and the rates of HER2 low expression, ER positivity, and PR positivity were higher than those of female patients (Table 1). This evidence concerns the gene ESR1 and breast carcinoma.